iOrganBio Appoints NeuroMetabolism Expert Dr. Zhiping Pang to Scientific Advisory Board

iOrganBio, an innovator in intelligent cell manufacturing, today announced the appointment of Zhiping Pang, M.D., Ph.D., to its Scientific Advisory Board. Dr. Pang is the Henry Rutgers Professor of NeuroMetabolism and Professor of Neuroscience and Cell Biology at Rutgers Robert Wood Johnson Medical School and Director of the Center for NeuroMetabolism at Rutgers Health. With over 140 publications in top journals including Nature, Science, Nature Neuroscience, and Nature Metabolism, he is recognized as a leading expert in human neuron biology, synaptic function, and the molecular mechanisms underlying neuropsychiatric and metabolic disorders.

This appointment strengthens iOrganBio's scientific breadth as the field moves toward more human-relevant, non-animal systems. The company's CellForge™ platform uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At its core is the functional human CellAtlas™, a comprehensive reference built from single-cell and multi-omics data that provides digital blueprints for each cell type. This smart, closed-loop process aims to deliver accuracy, efficiency, and quality for disease modeling, regenerative medicine, and drug development.

Dr. Pang's expertise in neuropsychiatric and metabolic disorders is particularly relevant given the growing need for FDA-aligned New Approach Methodologies (NAMs) that reduce reliance on animal testing. His addition is expected to bolster iOrganBio's position as a leader in AI-enabled, scalable, human cell and organoid production. The company's CellForge platform applies engineering precision to biology, enabling consistent and scalable manufacturing of cells and organoids for in vitro modeling and cell therapies.

For more information about iOrganBio and its technologies, visit iOrgan.Bio or follow on LinkedIn.